MYC and Burkitt lymphoma: Some key findings include the predominance of ID3 mutations in Burkitt lymphoma, but not in other IGH-MYC rearranged lymphomas [12], as well as the role of aberrant somatic hypermutation (aSHM) in Epstein-Barr positive Burkitt Lymphomas [11].